Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7287 p209
21 February 2004

This article
Reprint
Photocopy


News summary

Related websites
Moss Pharmacy (www.mosspharmacy.co.uk)


Moss Pharmacy launches healthy heart campaign

Risk profiling should become an integral part of the pharmacist’s role

Moss Pharmacy has launched the first stages of its new public health strategy “At the heart of your health”, addressing coronary heart disease.

Customers visiting any Moss Pharmacy are able to complete a multiple choice diet and lifestyle questionnaire. Their score is reviewed by the pharmacist and customers may be given advice or asked to revisit the store to discuss other steps. A booklet entitled “At the heart of your health” is available for customers, containing facts about the disease and practical advice for maintaining a healthy heart.

In selected Moss pharmacies, the pharmacist will also carry out a cardiac risk assessment. Based on the Framingham heart study, this is a more detailed clinical assessment taking into account risk factors such as the patient’s age and family history, and includes blood pressure testing. Patients will be given an action plan by the pharmacist, or referred on as appropriate, and may be invited back to the pharmacy for a progress check. Patients will not be charged for this service.

The strategy is supported by research carried out in conjunction with North West London NHS Trust.

Speaking at the campaign launch, Tricia Kennerley, NHS services director and superintendent pharmacist for Moss, said the company would like to see patients monitored for CHD risk factors in the pharmacy on an ongoing basis. She said: “Risk profiling should be routine, and become an integral part of the pharmacist’s role, not just a one-off.”

Subsequent steps of the campaign to be rolled out in the next few months will focus on smoking, obesity and weight management, diabetes and blood pressure.

Ms Kennerley told The Journal: “We are acutely aware of the importance of community pharmacy’s role in supporting the Government’s target to reduce the incidence of CHD. We anticipate that we will be able to use the outcomes from this initiative to inform and support primary care trusts in shaping services to meet their local patient needs. Going forward, we believe this type of initiative will be funded through the new pharmacy contract framework.”

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal